NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

<p>Patent allowance strengthens IP portfolio and positions company in pursuing drug delivery using its neural probes EDEN PRAIRIE, Minn., Nov. 16, 2023 (GLOBE NEWSWIRE) — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today […]</p>
<p>The post <a href="https://forextv.com/top-news/neuroone-announces-patent-allowance-for-drug-delivery-utilizing-a-novel-neural-probe/">NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>